Table 4
Most common prescription medications used in the past month, by age group and medication class, household population aged 3 to 19 years, Canada excluding the territories, 2012 to 2017


Table 4
Most common prescription medications used in the past month, by age group and medication class, household population aged 3 to 19 years, Canada excluding the territories, 2012 to 2017
Table summary
This table displays the results of Most common prescription medications used in the past month. The information is grouped by Age group (years), ATC code and medication class (appearing as row headers), Number '000, Prevalence, % and 95% confidence interval (appearing as column headers).
Age group (years), ATC code and medication class Number '000 Prevalence
% 95% confidence interval
from to
3 to 19
N06 - Psychoanaleptics 363 5.6 4.7 6.6
N06A - Antidepressants 150 2.3 1.8 3.0
N06B - Psychostimulants, agents used for ADHD and nootropics 233 3.6 2.8 4.6
G03 - Sex hormones and modulators of the genital system 276 8.7 7.1 10.7
G03A - Hormonal contraceptives for systemic use 269 8.5 6.9 10.4
R03 - Drugs for obstructive airway diseases 265 4.1 3.4 4.9
R03A - Adrenergics, inhalants 222 3.4 2.8 4.2
R03B - Other drugs for obstructive airway diseases, inhalants 141 2.2 1.7 2.8
J01 - Antibacterials for systemic use 168 2.6 2.0 3.3
J01C - Beta-lactam antibacterials, penicillins 98 1.5 1.1 2.1
D10 - Anti-acne preparations 76 1.2 0.9 1.5
D10A - Anti-acne preparations for topical use 64 1.0 0.7 1.4
D07 - Corticosteroids, dermatological preparations 70 1.1 0.8 1.5
D07A - Corticosteroids, plain 55 0.9 0.6 1.2
N05 - Psycholeptics 69 1.1Note E: Use with caution 0.8 1.5
N05A - Antipsychotics 39 0.6Note E: Use with caution 0.3 1.1
R01 - Nasal preparations 68 1.0Note E: Use with caution 0.7 1.6
R01A - Decongestants and other nasal preparations for topical use 68 1.0Note E: Use with caution 0.7 1.6
N02 - Analgesics 67 1.0Note E: Use with caution 0.7 1.5
N02B - Other analgesics and antipyretics 38 0.6Note E: Use with caution 0.3 1.1
M01 - Anti-inflammatory and antirheumatic products 55 0.8 0.6 1.2
M01A - Anti-inflammatory and antirheumatic products, non-steroids 55 0.8 0.6 1.2
A02 - Drugs for acid-related disorders 38 0.6Note E: Use with caution 0.4 0.9
A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) 38 0.6Note E: Use with caution 0.3 1.0
R06 - Antihistamines for systemic use 31 0.5Note E: Use with caution 0.3 0.8
R06A - Antihistamines for systemic use 31 0.5Note E: Use with caution 0.3 0.8
3 to 5
R03 - Drugs for obstructive airway diseases 46 4.1 3.0 5.6
R03A - Adrenergics, inhalants 36Note E: Use with caution 3.2Note E: Use with caution 2.2 4.7
R03B - Other drugs for obstructive airway diseases, inhalants 36Note E: Use with caution 3.2Note E: Use with caution 2.1 4.8
J01 - Antibacterials for systemic use 33Note E: Use with caution 2.9Note E: Use with caution 2.0 4.2
J01C - Beta-lactam antibacterials, penicillins 26Note E: Use with caution 2.3Note E: Use with caution 1.5 3.5
D07 - Corticosteroids, dermatological preparations 14Note E: Use with caution 1.3Note E: Use with caution 0.7 2.2
D07A - Corticosteroids, plain 14Note E: Use with caution 1.3Note E: Use with caution 0.7 2.3
A06 - Drugs for constipation 4Note E: Use with caution 0.4Note E: Use with caution 0.2 0.7
A06A - Drugs for constipation 4Note E: Use with caution 0.4Note E: Use with caution 0.2 0.7
6 to 11
N06 - Psychoanaleptics 86Note E: Use with caution 3.9Note E: Use with caution 2.7 5.5
N06B - Psychostimulants, agents used for ADHD and nootropics 84Note E: Use with caution 3.8Note E: Use with caution 2.6 5.5
R03 - Drugs for obstructive airway diseases 82 3.7 2.9 4.6
R03A - Adrenergics, inhalants 68 3.1 2.3 4.1
R03B - Other drugs for obstructive airway diseases, inhalants 49 2.2 1.5 3.1
J01 - Antibacterials for systemic use 48Note E: Use with caution 2.1Note E: Use with caution 1.5 3.1
J01C - Beta-lactam antibacterials, penicillins 34Note E: Use with caution 1.5Note E: Use with caution 0.9 2.5
R01 - Nasal preparations 26Note E: Use with caution 1.2Note E: Use with caution 0.7 1.9
R01A - Decongestants and other nasal preparations for topical use 26Note E: Use with caution 1.2Note E: Use with caution 0.7 2.0
N05 - Psycholeptics 15Note E: Use with caution 0.7Note E: Use with caution 0.4 1.2
A11 - Vitamins 14Note E: Use with caution 0.6Note E: Use with caution 0.3 1.1
D07 - Corticosteroids, dermatological preparations 12Note E: Use with caution 0.6Note E: Use with caution 0.3 1.0
D07A - Corticosteroids, plain 7Note E: Use with caution 0.3Note E: Use with caution 0.2 0.5
12 to 19
G03 - Sex hormones and modulators of the genital system 276 18.3 14.7 22.0
G03A - Hormonal contraceptives for systemic use 269 17.6 14.3 21.5
N06 - Psychoanaleptics 271 8.6 7.1 10.3
N06A - Antidepressants 145 4.6 3.5 6.0
N06B - Psychostimulants, agents used for ADHD and nootropics 143 4.5 3.3 6.1
R03 - Drugs for obstructive airway diseases 138 4.4 3.3 5.8
R03A - Adrenergics, inhalants 118 3.7 2.7 5.2
R03B - Other drugs for obstructive airway diseases, inhalants 56 1.8Note E: Use with caution 1.0 3.0
J01 - Antibacterials for systemic use 88 2.8 2.0 3.8
J01C - Beta-lactam antibacterials, penicillins 38Note E: Use with caution 1.2Note E: Use with caution 0.7 2.2
D10 - Anti-acne preparations 75 2.4 1.8 3.1
D10A - Anti-acne preparations for topical use 64 2.0 1.5 2.8
N05 - Psycholeptics 52Note E: Use with caution 1.6Note E: Use with caution 1.1 2.5
N05A - Antipsychotics 31Note E: Use with caution 1.0Note E: Use with caution 0.5 2.0
N02 - Analgesics 48Note E: Use with caution 1.5Note E: Use with caution 0.9 2.6
D07 - Corticosteroids, dermatological preparations 43Note E: Use with caution 1.4Note E: Use with caution 0.8 2.3
D07A - Corticosteroids, plain 34Note E: Use with caution 1.1Note E: Use with caution 0.6 1.9
M01 - Anti-inflammatory and antirheumatic products 40Note E: Use with caution 1.3Note E: Use with caution 0.8 1.9
M01A - Anti-inflammatory and antirheumatic products, non-steroids 40Note E: Use with caution 1.3Note E: Use with caution 0.8 2.0
R01 - Nasal preparations 35Note E: Use with caution 1.1Note E: Use with caution 0.6 2.0
R01A - Decongestants and other nasal preparations for topical use 35Note E: Use with caution 1.1Note E: Use with caution 0.6 2.1
A02 - Drugs for acid-related disorders 26Note E: Use with caution 0.8Note E: Use with caution 0.5 1.5
A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) 26Note E: Use with caution 0.8Note E: Use with caution 0.4 1.5
R06 - Antihistamines for systemic use 22Note E: Use with caution 0.7Note E: Use with caution 0.4 1.3
R06A - Antihistamines for systemic use 22Note E: Use with caution 0.7Note E: Use with caution 0.4 1.4
N03 - Anti-epileptics 19Note E: Use with caution 0.6Note E: Use with caution 0.3 1.1
N03A - Anti-epileptics 19Note E: Use with caution 0.6Note E: Use with caution 0.3 1.2
E use with caution
Notes: ATC = Anatomical Therapeutic Chemical, ADHD = Attention deficit hyperactivity disorder. Estimates for medication subclasses (four-digit) may not sum to the estimate for medication class (three-digit) when individuals were prescribed more than one medication within the same three-digit class. Estimates for sex hormones and modulators of the genital system (G03) are for females only.
Source: 2012 to 2013, 2014 to 2015 and 2016 to 2017 Canadian Health Measures Surveys, combined.

More information

ISSN: 1209-1367

Note of appreciation

Canada owes the success of its statistical system to a long-standing partnership between Statistics Canada, the citizens of Canada, its businesses, governments and other institutions. Accurate and timely statistical information could not be produced without their continued co-operation and goodwill.

Standards of service to the public

Statistics Canada is committed to serving its clients in a prompt, reliable and courteous manner. To this end, the Agency has developed standards of service which its employees observe in serving its clients.

Copyright

Published by authority of the Minister responsible for Statistics Canada.

© Her Majesty the Queen in Right of Canada as represented by the Minister of Industry, 2021

All rights reserved. Use of this publication is governed by the Statistics Canada Open Licence Agreement.

Catalogue no. 82-003-X

Frequency: Monthly

Ottawa

Report a problem on this page

Is something not working? Is there information outdated? Can't find what you're looking for?

Please contact us and let us know how we can help you.

Privacy notice

Date modified: